Revance to Release Second Quarter 2020 Financial Results on Thursday, August 6, 2020
Conference Call Scheduled for
Individuals interested in listening to the conference call may do so by dialing (855) 453-3827 for domestic callers, or (484) 756-4301 for international callers and reference conference ID: 4968933; or from the webcast link in the investor relations section of the company’s website at: www.revance.com.
A replay of the call will be available beginning
In light of reduced call center resources during this time of required social-distancing, Revance requests listeners not planning on participating in Q&A to listen to the live webcast rather than dialing in by phone.
“Revance Therapeutics” and the Revance logo are registered trademarks of
Resilient Hyaluronic Acid® and RHA® are trademarks of
BOTOX® is a registered trademark of
Jenifer Slaw, 347-971-0906
Nadine Tosk, 504-453-8344